Helicobacter pylori, commonly known as H. pylori, is a gram-negative bacterium that colonizes the human stomach. It is estimated that over half of the world's population is infected with this microorganism, making it one of the most widespread infections. While H. pylori colonization is often asymptomatic, it can lead to various gastric diseases, including gastritis, peptic ulcers, and even gastric cancer. The pathogenicity of H. pylori is attributed to its arsenal of virulence factors, which enable it to survive in the hostile gastric environment and manipulate the host's immune response. This article aims to explore the key virulence factors of H. pylori and their role in the development of gastric diseases.
Figure 1. Helicobacter pylori virulence factors associated with gastric pathogenic processes.
H. pylori's initial step in establishing an infection is attaching itself to the gastric epithelial cells. Adhesion is mediated by several factors, with the most crucial one being the bacterial adhesin BabA. BabA binds to the Lewis b (Leb) antigen on the surface of gastric cells, promoting firm attachment and colonization. Moreover, SabA, another adhesin, facilitates binding to sialyl-Lewis a (sLea) antigens, further reinforcing the bacterium's attachment to gastric cells. By firmly adhering to the gastric mucosa, H. pylori evades the natural peristaltic movements of the stomach, allowing it to persist and cause chronic infections.
One of H. pylori's most notable virulence factors is urease, an enzyme that converts urea into ammonia and bicarbonate. Urease serves two critical purposes for the bacterium. First, it neutralizes the acidic environment of the stomach, providing a favorable pH for the bacteria's survival. Second, the ammonia produced by urease enhances the bacterium's ability to colonize the gastric mucosa by counteracting the harmful effects of gastric acid. Additionally, urease-generated ammonia can contribute to the development of gastritis, as it damages gastric epithelial cells and triggers an inflammatory response.
CagA (Cytotoxin-associated gene A)
The cagA gene encodes for the cytotoxin CagA, a highly influential virulence factor of H. pylori. The CagA protein is delivered into gastric epithelial cells via a type IV secretion system (T4SS). Once inside the host cell, CagA undergoes phosphorylation, leading to alterations in various cellular processes. Phosphorylated CagA disrupts cell-to-cell adhesion, triggers cell elongation, and causes cellular stress, which can eventually lead to cellular damage and dysfunction. CagA also manipulates intracellular signaling pathways, promoting inflammation and creating an environment conducive to carcinogenesis. Strains of H. pylori carrying the cagA gene are associated with an increased risk of developing peptic ulcers and gastric cancer.
VacA (Vacuolating Cytotoxin A)
VacA is another crucial toxin produced by H. pylori. It is secreted by the bacterium and enters gastric epithelial cells, where it causes cellular vacuolation, disrupting the normal cellular functions. VacA also targets immune cells, such as T cells, macrophages, and dendritic cells, suppressing the host's immune response and promoting bacterial survival. This immunomodulatory effect can lead to persistent infection and chronic inflammation, contributing to the pathogenesis of gastric diseases.
Outer Inflammatory Protein (OipA)
The Outer Inflammatory Protein A (OipA) is a key factor in H. pylori-induced inflammation. It triggers the production of pro-inflammatory cytokines, such as interleukin-8 (IL-8), which recruits immune cells to the site of infection. OipA also disrupts the integrity of the gastric mucosal barrier, further promoting inflammation and tissue damage. As a result, OipA plays a significant role in the development of gastritis and peptic ulcers associated with H. pylori infection.
H. pylori is a successful gastric pathogen due to its diverse array of virulence factors that enable it to colonize and persist in the hostile gastric environment. Adhesion factors, urease, CagA, VacA, and OipA all play vital roles in H. pylori's ability to establish chronic infections and promote the development of gastric diseases. Understanding these virulence factors is essential for developing effective strategies to combat H. pylori infections and prevent associated gastric diseases, including gastric cancer. Further research in this area may pave the way for new therapeutic approaches and potential vaccines to tackle this global health burden.
- Molina-Castro S, et al.; Priming the seed: Helicobacter pylori alters epithelial cell invasiveness in early gastric carcinogenesis. World J Gastrointest Oncol. 2018, 10(9):231-243.
※ All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.